Business Description
Hunan Nucien Pharmaceutical Co Ltd
Share Class Description:
SHSE:688189: Class ACompare
Compare
Traded in other countries / regions
688189.China IPO Date
2020-03-26Description
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.88 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -1.01 | |||||
| Interest Coverage | 10.25 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.07 | |||||
| Beneish M-Score | -2.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.1 | |||||
| 3-Year EBITDA Growth Rate | -32.5 | |||||
| 3-Year EPS without NRI Growth Rate | -65.2 | |||||
| 3-Year Book Growth Rate | -6.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.55 | |||||
| 9-Day RSI | 29.22 | |||||
| 14-Day RSI | 33.13 | |||||
| 6-1 Month Momentum % | 39.29 | |||||
| 12-1 Month Momentum % | -15.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.93 | |||||
| Quick Ratio | 5.49 | |||||
| Cash Ratio | 2.53 | |||||
| Days Inventory | 103.17 | |||||
| Days Sales Outstanding | 469.72 | |||||
| Days Payable | 92.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 15.96 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.12 | |||||
| Operating Margin % | 18.97 | |||||
| Net Margin % | -16.8 | |||||
| FCF Margin % | 24.32 | |||||
| ROE % | -5.3 | |||||
| ROA % | -4.28 | |||||
| ROIC % | 8.39 | |||||
| ROC (Joel Greenblatt) % | -9.67 | |||||
| ROCE % | -5.11 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 33.07 | |||||
| PS Ratio | 4.26 | |||||
| PB Ratio | 1.39 | |||||
| Price-to-Tangible-Book | 1.68 | |||||
| Price-to-Free-Cash-Flow | 17.76 | |||||
| Price-to-Operating-Cash-Flow | 11.25 | |||||
| EV-to-EBIT | -20.85 | |||||
| EV-to-EBITDA | -20.85 | |||||
| EV-to-Revenue | 3.35 | |||||
| EV-to-FCF | 13.78 | |||||
| Price-to-Projected-FCF | 7.35 | |||||
| Price-to-Graham-Number | 1.57 | |||||
| Price-to-Net-Current-Asset-Value | 2.2 | |||||
| Price-to-Net-Cash | 6.65 | |||||
| Earnings Yield (Greenblatt) % | -4.8 | |||||
| FCF Yield % | 5.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hunan Nucien Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 409.113 | ||
| EPS (TTM) (Â¥) | -0.251 | ||
| Beta | 1.01 | ||
| Volatility % | 38.89 | ||
| 14-Day RSI | 33.13 | ||
| 14-Day ATR (Â¥) | 0.312735 | ||
| 20-Day SMA (Â¥) | 7.053 | ||
| 12-1 Month Momentum % | -15.47 | ||
| 52-Week Range (Â¥) | 5.22 - 9.27 | ||
| Shares Outstanding (Mil) | 274.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hunan Nucien Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hunan Nucien Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hunan Nucien Pharmaceutical Co Ltd Frequently Asked Questions
What is Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189)'s stock price today?
The current price of SHSE:688189 is ¥6.25. The 52 week high of SHSE:688189 is ¥9.27 and 52 week low is ¥5.22.
When is next earnings date of Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189)?
The next earnings date of Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) is .
Does Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) pay dividends? If so, how much?
Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers